Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-03-26 @ 3:21 PM
NCT ID:
NCT00556127
Eligibility Criteria:
Inclusion Criteria:
* previously untreated aggressive B-cell lymphoma (Diffuse Large B-Cell,
* Primary Mediastinal,
* Follicular grade III b Lymphoma);
* age 18 to 60;
* III-IV Ann Arbor stage;
* 0-2 Eastern Cooperative Oncology Group (ECOG) performance status (PS);
* intermediate-high (IH) and high (H) risk score according to age-adjusted International Prognostic Index (IPI).
* Patients with Primary Mediastinal Lymphoma were included only if they had advanced stage III or IV disease.
Exclusion Criteria:
* HIV,
* hepatitis B or C virus seropositivity;
* CNS involvement at diagnosis;
* abnormal renal, pulmonary and hepatic function;
* left ventricular ejection fraction less than 45%;
* pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00556127
Study Brief:
Protocol Section:
NCT00556127